Literature DB >> 1759508

Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.

E Relyveld1, N H Oato, N Guérin, P Coursaget, M Huet, R K Gupta.   

Abstract

The antibody response to pertussis toxin (PT) and agglutinogens of children vaccinated in Japan, France and Senegal with either whole cell or component pertussis vaccine was determined at various times after immunization. Agglutinin titres were almost similar in sera of Japanese children vaccinated with either whole cell or component pertussis vaccine whereas anti-PT antibody levels were found to be higher after vaccination with whole cell vaccine than with component vaccine. The geometric mean (GM) agglutinin titres in sera of Japanese children amounted to 45.0 and 45.7, respectively, and neutralization GM titres to 71.6 and 22.6, respectively, following vaccination with the whole cell and component pertussis vaccines. Sera of French children receiving three doses of whole cell vaccine exhibited a GM agglutinin titre of 17.8, whereas only 16% of sera contained neutralizing antibodies against PT. Following the booster dose the GM agglutinin titre rose to 213.5 and 68% of the sera contained neutralizing antibodies to PT (GM titre 48.0). Sera of Senegalese children receiving three doses of whole cell vaccine exhibited a GM agglutinin titre of 18.7, whereas anti-PT neutralizing antibodies were hardly detected. Agglutinins and anti-PT antibody in sera of French and Senegalese children turned out to be lower than were found 25 years ago in sera of children immunized with the French whole cell pertussis vaccine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759508     DOI: 10.1016/0264-410x(91)90224-t

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Authors:  E Grimprel; P Bégué; I Anjak; E Njamkepo; P François; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

2.  Western blot analysis of antibody responses of young infants to pertussis infection.

Authors:  N Guiso; E Grimprel; I Anjak; P Bégué
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

3.  Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa.

Authors:  Mathurin C Tejiokem; Elisabeth Njamkepo; Ionela Gouandjika; Dominique Rousset; Lydie Béniguel; Catherine Bilong; Gilbert Tene; Ida Penda; Carine Ngongueu; Jean C Gody; Nicole Guiso; Laurence Baril
Journal:  Clin Vaccine Immunol       Date:  2009-02-04

4.  DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old.

Authors:  Hartono Gunardi; Kusnandi Rusmil; Eddy Fadlyana; Meita Dhamayanti; Rini Sekartini; Rodman Tarigan; Hindra Irawan Satari; Bernie Endyarni Medise; Rini Mulia Sari; Novilia Sjafri Bachtiar; Cissy B Kartasasmita; Sri Rezeki S Hadinegoro
Journal:  BMC Pediatr       Date:  2018-05-28       Impact factor: 2.125

5.  HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.

Authors:  Mathurin C Tejiokem; Ionela Gouandjika; Lydie Béniguel; Marie-Claire Endegue Zanga; Gilbert Tene; Jean C Gody; Elisabeth Njamkepo; Anfumbom Kfutwah; Ida Penda; Catherine Bilong; Dominique Rousset; Régis Pouillot; Frédéric Tangy; Laurence Baril
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

6.  Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran.

Authors:  Vajiheh Sadat Nikbin; Nazanin Jannesar Ahmadi; Maryam Hosseinpour; Masoumeh Nakhost Lotfi; Fahimeh Shooraj; Fatemeh Sadeghpour; Fereshteh Shahcheraghi
Journal:  Int J Mol Cell Med       Date:  2015
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.